The Queen Elizabeth Hospital is based in Sheriff Hill in Gateshead, England. It is managed by Gateshead Health NHS Foundation Trust.

During the past decade, Queen Elizabeth Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 2 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen Elizabeth Hospital" #1 sponsor was "University College, London" with 4 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored, "Medical Research Council" with 3 trials sponsored, "University of Edinburgh" with 3 trials sponsored and "Newcastle-upon-Tyne Hospitals NHS Trust" with 3 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Elizabeth Hospital" #1 collaborator was "Cancer Research UK" with 3 trials as a collaborator, "NHS Lothian" with 3 trials as a collaborator, "Newcastle-upon-Tyne Hospitals NHS Trust" with 2 trials as a collaborator, "Roche Pharma AG" with 2 trials as a collaborator and "University of Cambridge" with 2 trials as a collaborator. Other collaborators include 50 different institutions and companies that were collaborators in the rest 60 trials.

According to Clinical.Site data, the most researched conditions in "Queen Elizabeth Hospital" are "Breast Cancer" (6 trials), "Fallopian Tube Cancer" (4 trials), "Lymphoma" (4 trials), "Ovarian Cancer" (4 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Queen Elizabeth Hospital" in a lesser frequency.

Most popular intervention types in "Queen Elizabeth Hospital" are "Drug" (23 trials), "Procedure" (10 trials), "Biological" (8 trials), "Other" (8 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (5 trials), "adjuvant therapy" (4 trials), "capecitabine" (3 trials), "paclitaxel" (3 trials) and "quality-of-life assessment" (3 trials). Other intervention names were less common.

The vast majority of trials in "Queen Elizabeth Hospital" are 27 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Queen Elizabeth Hospital". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 19 completed trials in Queen Elizabeth Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Queen Elizabeth Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".